No profile data available.
Deltex Medical Group plc (DTXMF) is a healthcare company in the targeted healthcare equipment industry, based in Chichester, United Kingdom, with about 24 full-time employees.
It reported revenue of 1.78 million GBP for fiscal year 2023, down 28.4% from fiscal year 2022, and net income of -1.28 million GBP. Its market capitalization was $180.58 million as of August 4, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2023; market data as of August 4, 2026.
Deltex Medical Group plc, together with its subsidiaries, manufactures, markets, and sells oesophageal doppler and pulse contour analysis and monitoring platform. It offers dopplink, a patient interface cable; and pressurewave, an arterial blood pressure signal under the TrueVue brand. The company also provides oesophageal doppler monitoring systems.
Deltex Medical Group reported 1.78 million GBP in revenue for fiscal year 2023, down 28.4% from 2.48 million GBP in fiscal year 2022.
$180.58 million as of August 4, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include Utah Medical Products, Inc. (UTMD), Electromed, Inc. (ELMD), RxSight, Inc. (RXST), Inogen, Inc. (INGN).